Skip to main content
Jonathan Krakoff, MD, Endocrinology, Phoenix, AZ

Jonathan A Krakoff MD

Diabetes, Lipid Metabolism, Thyroid


Physician

Join to View Full Profile
  • 4212 N 16th StPhoenix, AZ 85016

  • Phone+1 602-200-5217

  • Fax+1 602-200-5335

Dr. Krakoff is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1998 - 2001
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Internal Medicine, 1989 - 1992
  • New York University School of Medicine
    New York University School of MedicineClass of 1989

Certifications & Licensure

  • AZ State Medical License
    AZ State Medical License 1999 - 2026
  • NY State Medical License
    NY State Medical License 1991 - 2001
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Endocrinology, Diabetes and Metabolism
    American Board of Internal Medicine Endocrinology, Diabetes and Metabolism

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Endocannabinoid Anandamide Mediates the Effect of Skeletal Muscle Sphingomyelins on Human Energy Expenditure  
    Jonathan Krakoff, MD, The Journal of Clinical Endocrinology and Metabolism
  • FGF21 Is a Hormonal Mediator of the Human “Thrifty” Metabolic Phenotype  
    Jonathan Krakoff, Clifton Bogardus, Karyne L Vinales, Diabetes Care

Authored Content

  • Exenatide Has a Pronounced Effect on Energy Intake but Not Energy Expenditure in Non-Diabetic Subjects with Obesity: A Randomized, Double-Blind, Placebo-Controlled Trial☆March 2018

Press Mentions

  • Metabolites and Diabetes Remission After Weight Loss
    Metabolites and Diabetes Remission After Weight LossFebruary 24th, 2021
  • Long-Term Effects of a Lifestyle Intervention on Weight and Cardiovascular Risk Factors in Individuals with Type 2 Diabetes MellitusFour-Year Results of the Look AHEAD Trial
    Long-Term Effects of a Lifestyle Intervention on Weight and Cardiovascular Risk Factors in Individuals with Type 2 Diabetes MellitusFour-Year Results of the Look AHEAD TrialOctober 20th, 2016

Grant Support

  • Risk Factors And Etiology Of Obesity And Type 2 DiabetesNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
  • Regulators Of Food IntakeNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
  • Nutrient Absorption In Lean Versus Obese IndividualsNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
  • Neuronal Activity And Its Role In Adiposity And Food IntakeNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
  • Mechanism And Effect Of Exenatide On Weight Loss: Randomized Controlled TrialNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
  • Factors Which Predict Variance In Weight ChangeNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2011
  • The Effect Of Salsalate On Insulin Action And SecretionNational Institute Of Diabetes And Digestive And Kidney Diseases2009–2010
  • The Effect Of Salsalate On Insulin Action And SecretionNational Institute Of Diabetes And Digestive And Kidney Diseases2008
  • Neuronal Activity And Its Role In Adiposity And Food IntakeNational Institute Of Diabetes And Digestive And Kidney Diseases2008

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: